Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

RXRXRXRX
Showing 8 of 21 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in RECURSION PHARMACEUTICALS IN

NORTHERN TRUST CORP holds 4.8M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $17.5M as of 2026-Q2. The position was increased (+19.9% shares). RXRX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$17.5M

Current Shares

4.8M

Total Value Change

+$4.1M

Total Shares Change

+2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.8M
+19.9%
$17.5M0.0%$3.67
34
2026-Q1
Increased
4M
+15.4%
$12.2M0.0%$3.54
32
2025-Q4
Increased
3.4M
+3.1%
$14.1M0.0%$4.11
29
2025-Q3
Increased
3.3M
+14.5%
$16.3M0.0%$4.91
32
2025-Q2
Increased
2.9M
+21.7%
$14.7M0.0%$5.03
34
2025-Q1
Increased
2.4M
+0.0%
$12.7M0.0%$5.81
28
2024-Q4
Increased
2.4M
+18.4%
$16.2M0.0%$6.77
33
2024-Q3
Increased
2M
+53.9%
$13.3M0.0%$6.98
39

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used